In Silicon Valley, some technology professionals are adopting smoking as a symbol of their confidence in artificial intelligence (AI) to eventually cure cancer, despite the well-known health risks associated with tobacco use. This trend reflects a broader optimism within the tech community about AI’s potential to revolutionize healthcare.
Shyam Sankar, chief technology officer at Palantir, described smoking among researchers as a way to signal their commitment to AI advancements. “I believe so much in AI that it’s going to cure cancer, so I’m showing you my chips are all in,” he said. Avi Schiffmann, a 23-year-old AI startup founder based in the San Francisco Bay Area, echoed this sentiment, expressing the expectation that health risks related to smoking may diminish within the next decade due to medical breakthroughs driven by AI.
Other tech workers shared similar perspectives. One San Francisco-based employee stated a strong belief that AI will solve many healthcare challenges and anticipated that cancer could be cured within 20 years as a result of AI-powered innovations. For some, smoking also serves social and networking purposes. Stephen Campbell, co-founder of Revamp AI, acknowledged the health dangers of smoking but described it as offering a rare moment to step away from constant productivity pressures and connect with peers.
Companies within the tech sector have also adapted to this cultural shift by providing nicotine products in workplace settings. Palantir has installed vending machines dispensing free nicotine pouches in its Washington offices, while the Texas-based startup Hello Patient introduced similar products after recognizing their use among engineers for maintaining focus during demanding work hours.
Despite this growing acceptance among some tech insiders, smoking remains the leading preventable cause of cancer in the United States, contributing to 30 percent of cancer-related deaths. Medical experts continue to warn against its risks.
At the same time, major figures in the AI field express optimism about imminent medical breakthroughs. Rene Haas, CEO of Arm Holdings, recently stated his conviction that AI will enable a cancer cure within our lifetime by advancing DNA analysis and speeding up drug discovery. Demis Hassabis, Nobel laureate and CEO of Google DeepMind, suggested that such a cure could arrive in five to ten years. Sam Altman, CEO of OpenAI, also expressed confidence that diseases will soon be treated at an unprecedented rate due to AI technologies.
This juxtaposition underscores a broader debate within the tech community about the balance between current health risks and future scientific promises, illustrating how faith in AI is shaping attitudes toward habits traditionally viewed as harmful.